These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21513501)

  • 1. Protein kinases as drug targets.
    Yli-Kauhaluoma J; Tuominen RK
    Curr Top Med Chem; 2011; 11(11):1304. PubMed ID: 21513501
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies.
    Bagrodia S; Smeal T; Abraham RT
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):819-31. PubMed ID: 22883054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
    Huang Z; Lee MH
    Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
    [No Abstract]   [Full Text] [Related]  

  • 4. Small molecule kinase inhibitors as anti-cancer therapeutics.
    Chahrour O; Cairns D; Omran Z
    Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation.
    Trusolino L; Bertotti A
    Cancer Discov; 2012 Oct; 2(10):876-80. PubMed ID: 23071031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian target of rapamycin kinase and tumor growth inhibition.
    Boulay A; Lane HA
    Recent Results Cancer Res; 2007; 172():99-124. PubMed ID: 17607938
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein kinases in cancer: recent findings.
    Schenone S
    Curr Med Chem; 2011; 18(19):2826. PubMed ID: 21651497
    [No Abstract]   [Full Text] [Related]  

  • 8. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).
    Ardito F; Giuliani M; Perrone D; Troiano G; Lo Muzio L
    Int J Mol Med; 2017 Aug; 40(2):271-280. PubMed ID: 28656226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review.
    Kwiecień H; Goszczyńska A; Rokosz P
    Curr Pharm Des; 2016; 22(7):879-94. PubMed ID: 26648467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations of protein kinases and individualised cancer therapy.
    Davies M; Hennessy B; Mills GB
    Expert Opin Pharmacother; 2006 Nov; 7(16):2243-61. PubMed ID: 17059381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the selectivity of kinase inhibitors in oncology: a chemical biology perspective.
    Maddox S; Hecht D; Gustafson JL
    Future Med Chem; 2016; 8(3):241-4. PubMed ID: 26898835
    [No Abstract]   [Full Text] [Related]  

  • 12. PI3K inhibitors for cancer treatment: where do we stand?
    Maira SM; Stauffer F; Schnell C; García-Echeverría C
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):265-72. PubMed ID: 19143644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinases as Tumor Biomarkers and Therapeutic Targets.
    Quan C; Xiao J; Liu L; Duan Q; Yuan P; Zhu F
    Curr Pharm Des; 2017 Nov; 23(29):4209-4225. PubMed ID: 28730960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.
    Carlino L; Rastelli G
    J Med Chem; 2016 Oct; 59(20):9305-9320. PubMed ID: 27559828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of targeting protein kinases in cancer therapeutics.
    Tsai CJ; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):235-42. PubMed ID: 23651790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
    Fabbro D
    Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosensors for Screening Kinase Inhibitors.
    Bhalla N; Estrela P
    Curr Top Med Chem; 2017; 17(22):2470-2481. PubMed ID: 28558640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Landscape of Atypical and Eukaryotic Protein Kinases.
    Kanev GK; de Graaf C; de Esch IJP; Leurs R; Würdinger T; Westerman BA; Kooistra AJ
    Trends Pharmacol Sci; 2019 Nov; 40(11):818-832. PubMed ID: 31677919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the computational toolbox for interrogating cancer kinomes.
    Tan AC; Ryall KA; Huang PH
    Pharmacogenomics; 2016; 17(2):95-7. PubMed ID: 26666839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.